Oryzon Genomics S.A. (0RDB.L) Dividend Yield, History & Forecast
Oryzon Genomics S.A. (0RDB.L) is a Medical - Pharmaceuticals company in the Healthcare sector listed on the London Stock Exchange. The most recent ex-dividend date was March 15, 2022. market capitalization is approximately $218M.
Frequently Asked Questions about Oryzon Genomics S.A. (0RDB.L)
When does Oryzon Genomics S.A. pay its next dividend?▾
The most recent ex-dividend date was March 15, 2022.
Is Oryzon Genomics S.A. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Oryzon Genomics S.A. in?▾
Oryzon Genomics S.A. (0RDB.L) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry.
